article
12 June 2016 | By Mona Elbadawi-Sidhu (NIH West Coast Metabolomics Center), Oliver Fiehn (NIH West Coast Metabolomics Center)
Blanketed administration of drugs to all populations assumes that all patients respond similarly. Despite pharmaceutical companies’ efforts to develop drugs with large therapeutic windows, there are often and inevitably subpopulations of individuals who will either not respond to therapy or will respond with adverse effects...